Simon Lønbro1,2, Gry Bjerg Petersen1, Jens Rikardt Andersen3, Jørgen Johansen4. 1. Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark. 2. Department of Public Health, Section for Sports Science, Aarhus University, Aarhus, Denmark. 3. Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark. 4. Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense C, Denmark. j.johansen@dadlnet.dk.
Abstract
PURPOSE: The aims of the present study were to explore pre-treatment predictors of weight loss during radiation treatment only in head and neck cancer (HNSCC) patients and investigate the weight loss in patients with or without a feeding tube. METHODS: Retrospectively, weight change during curative radiotherapy was investigated in 476 consecutive HNSCC patients. Independent predictors were identified using multivariate regression analysis with weight loss below or above 5 % as the primary dependent variable. RESULTS: Baseline BMI, tumor site, and stage predicted weight loss above 5 %. The odds of weight loss above 5 % in patients with BMI >25 were 3.00 ± 0.64 times higher compared with patients with BMI <25 (p < 0.0001). Patients with pharyngeal, oral cavity, or supraglottic tumors had 3.12 ± 0.80 times higher odds of weight loss above 5 % compared with glottic cancer patients (p < 0.0001), and the odds were 1.68 ± 0.40 times higher in stage III-IV patients compared with stage I-II patients (p = 0.03). Seperate analyses revealed that tumor site and stage only predicted weight loss in patients with BMI >25 but not in patients with BMI <25. Patients receiving a feeding tube weighed less than patients without (73.8 vs 78.3 kg) and feeding tube reduced, but did not prevent, weight loss which averaged 6.7 ± 4.7 kg (7.4 ± 4.7 %) compared with 4.7 ± 5.9 kg (5.5 ± 6.0 %) in patients without a feeding tube (P < 0.0001). CONCLUSION: Pre-treatment BMI, tumor site and stage predicted weight loss above 5 % in HNSCC patients during radiotherapy. BMI should be considered when analyzing weight loss in HNSCC patients receiving curative radiotherapy.
PURPOSE: The aims of the present study were to explore pre-treatment predictors of weight loss during radiation treatment only in head and neck cancer (HNSCC) patients and investigate the weight loss in patients with or without a feeding tube. METHODS: Retrospectively, weight change during curative radiotherapy was investigated in 476 consecutive HNSCC patients. Independent predictors were identified using multivariate regression analysis with weight loss below or above 5 % as the primary dependent variable. RESULTS: Baseline BMI, tumor site, and stage predicted weight loss above 5 %. The odds of weight loss above 5 % in patients with BMI >25 were 3.00 ± 0.64 times higher compared with patients with BMI <25 (p < 0.0001). Patients with pharyngeal, oral cavity, or supraglottic tumors had 3.12 ± 0.80 times higher odds of weight loss above 5 % compared with glottic cancer patients (p < 0.0001), and the odds were 1.68 ± 0.40 times higher in stage III-IV patients compared with stage I-II patients (p = 0.03). Seperate analyses revealed that tumor site and stage only predicted weight loss in patients with BMI >25 but not in patients with BMI <25. Patients receiving a feeding tube weighed less than patients without (73.8 vs 78.3 kg) and feeding tube reduced, but did not prevent, weight loss which averaged 6.7 ± 4.7 kg (7.4 ± 4.7 %) compared with 4.7 ± 5.9 kg (5.5 ± 6.0 %) in patients without a feeding tube (P < 0.0001). CONCLUSION: Pre-treatment BMI, tumor site and stage predicted weight loss above 5 % in HNSCC patients during radiotherapy. BMI should be considered when analyzing weight loss in HNSCC patients receiving curative radiotherapy.
Entities:
Keywords:
Head and neck cancer; Malnutrition; Predictors; Tube feeding; Weight loss
Authors: Hanna R Mortensen; Jens Overgaard; Lena Specht; Marie Overgaard; Jørgen Johansen; Jan F Evensen; Lisbeth J Andersen; Elo Andersen; Cai Grau Journal: Radiother Oncol Date: 2012-03-05 Impact factor: 6.280
Authors: Jacqueline A E Langius; Anne M van Dijk; Patricia Doornaert; Hinke M Kruizenga; Johannes A Langendijk; C René Leemans; Peter J M Weijs; Irma M Verdonck-de Leeuw Journal: Nutr Cancer Date: 2013 Impact factor: 2.900
Authors: Jacqueline A E Langius; Myrna C Zandbergen; Simone E J Eerenstein; Maurits W van Tulder; C René Leemans; Mark H H Kramer; Peter J M Weijs Journal: Clin Nutr Date: 2013-06-26 Impact factor: 7.324
Authors: Robert Olson; Irene Karam; Gavin Wilson; Angela Bowman; Christopher Lee; Frances Wong Journal: Support Care Cancer Date: 2013-08-16 Impact factor: 3.603
Authors: Teresa Małecka-Massalska; Tomasz Powrózek; Monika Prendecka; Radosław Mlak; Grzegorz Sobieszek; Wojciech Brzozowski; Anna Brzozowska Journal: In Vivo Date: 2019 Sep-Oct Impact factor: 2.155
Authors: Alexander Stanforth; Liyong Lin; Jonathan J Beitler; James R Janopaul-Naylor; Chih-Wei Chang; Robert H Press; Sagar A Patel; Jennifer Zhao; Bree Eaton; Eduard E Schreibmann; James Jung; Duncan Bohannon; Tian Liu; Xiaofeng Yang; Mark W McDonald; Jun Zhou Journal: J Appl Clin Med Phys Date: 2022-02-07 Impact factor: 2.243
Authors: May Kay Neoh; Zalina Abu Zaid; Zulfitri Azuan Mat Daud; Nor Baizura Md Yusop; Zuriati Ibrahim; Zuwariah Abdul Rahman; Norshariza Jamhuri Journal: Nutrients Date: 2020-04-26 Impact factor: 5.717
Authors: Marcin Mazurek; Radosław Mlak; Iwona Homa-Mlak; Tomasz Powrózek; Anna Brzozowska; Wojciech Kwaśniewski; Grzegorz Opielak; Teresa Małecka-Massalska Journal: J Clin Med Date: 2022-02-02 Impact factor: 4.241
Authors: Hye Ri Han; Gregory M Hermann; Sung Jun Ma; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni A Kuriakose; Michael R Markiewicz; Jon M Chan; Mary E Platek; Andrew D Ray; Fangyi Gu; Wesley L Hicks; Anurag K Singh Journal: Ann Transl Med Date: 2021-05